Matching trials
1,853 results
- MAGELLANIndependent statistical analysis of Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MAGELLAN-3Independent statistical analysis of Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in…
- Magnesium vs Placebo for Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Magnesium vs Placebo for Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02218424).
- Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent: primary endpoint results, effect estimate…
- MAGNIFYIndependent statistical analysis of Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MAGNITUDEIndependent statistical analysis of the phase 3 MAGNITUDE trial of niraparib in combination with abiraterone acetate and prednisone versus abiraterone acetate and prednisone in castration-resistant prostate cancer, including rPFS, hazard ratios, confidence…
- MAHALEIndependent statistical analysis of Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Maintaining Nonsmoking: Older Smokers – 1: Complete Statistical AnalysisIndependent statistical analysis of Maintaining Nonsmoking: Older Smokers - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00086385).
- MAJICAn independent statistical analysis of the phase 3 MAJIC trial evaluating acalabrutinib plus venetoclax versus venetoclax plus obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.
- MamaMoveIndependent statistical analysis of A Home Exercise Program for Women With Infants & Young Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Management of Etonogestrel Subdermal Implant-related Bleeding: Complete Statistical AnalysisIndependent statistical analysis of Management of Etonogestrel Subdermal Implant-related Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01658995).
- Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage: Complete Statistical AnalysisIndependent statistical analysis of Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MANDALAA detailed statistical analysis of the phase 3 MANDALA trial of budesonide/albuterol metered-dose inhalers versus albuterol in adults and children 4 years of age or older with asthma, including time-to-event, rate, binary,…
- Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: Complete Statistical AnalysisIndependent statistical analysis of Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MATINEEAn independent statistical analysis of the phase 3 MATINEE trial of mepolizumab 100 mg versus placebo in COPD with frequent exacerbations and raised eosinophil levels, covering the negative binomial exacerbation-rate analysis, Cox…
- Mature B-Cell Lymphoma And Leukemia Study III: Complete Statistical AnalysisIndependent statistical analysis of Mature B-Cell Lymphoma And Leukemia Study III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046825).
- MDP 301Independent statistical analysis and educational interpretation of the randomized phase 3 MDP 301 trial evaluating PRO 2000/5 gel for prevention of vaginally acquired HIV infection, including trial design, endpoints, planned statistical methods,…
- MEASURE 1 extIndependent statistical analysis of Extension in AS: Sustainability of Benefits, Safety and Tolerability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01863732).
- MEDALISTIndependent statistical analysis of A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: Complete Statistical AnalysisIndependent statistical analysis of MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02332928).
- MELTEMIIndependent statistical analysis of A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…
- MERCURIndependent statistical analysis of A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MERMAID-1Independent statistical analysis of Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate…
- Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): Complete Statistical AnalysisIndependent statistical analysis of Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metvix PDT in Participant With “High Risk” Basal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00473343).
- MicroVasc-DIVAIndependent statistical analysis of Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Subclinical Inflammation and High Cardiovascular Risk: primary endpoint results, effect estimate with confidence interval,…
- Midodrine for the Treatment of Refractory Hypotension: Complete Statistical AnalysisIndependent statistical analysis of Midodrine for the Treatment of Refractory Hypotension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01531959).
- Midodrine Use in Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Midodrine Use in Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03706053).
- MINDACTIndependent statistical analysis of the MINDACT phase 3 trial, examining genetic testing and clinical assessment in determining the need for chemotherapy in women with breast cancer involving no more than 3 lymph…
- Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial: Complete Statistical AnalysisIndependent statistical analysis of Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03508830).
- Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MITO-7Independent statistical analysis of MITO-7, a randomized phase 3 trial comparing weekly versus every 3 week chemotherapy in patients with ovarian cancer.
- MITO-8Independent statistical analysis of the randomized phase 3 MITO-8 trial in ovarian cancer, including its crossover design, overall survival endpoint, planned analysis, and statistical interpretation.
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00482729).
- MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MMVAR – Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation: Complete Statistical AnalysisIndependent statistical analysis of MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MODERNIndependent statistical analysis of Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Modified Dakin’s Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: Complete Statistical AnalysisIndependent statistical analysis of Modulation of Human Myocardial Metabolism by GLP-1 Dose Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01607450).
- MONALEESA-2Complete statistical analysis of MONALEESA-2, the randomized phase 3 trial of ribociclib plus letrozole versus placebo plus letrozole in postmenopausal women with advanced or metastatic breast cancer.
- MONALEESA-7Independent statistical analysis of MONALEESA-7, a randomized phase 3 trial of ribociclib plus endocrine therapy and goserelin versus placebo plus endocrine therapy and goserelin in premenopausal women with hormone receptor-positive, HER2-negative advanced…
- MONARCH 3Independent statistical analysis of the phase 3 MONARCH 3 trial of abemaciclib plus a nonsteroidal aromatase inhibitor in postmenopausal women with breast cancer, including progression-free survival, response, health-status outcomes, methodology, safety, and…
- MONARCH plusIndependent statistical analysis of A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02763566).
- MONETIndependent statistical analysis of the randomized phase 3 MONET trial of darunavir/ritonavir once daily versus darunavir/ritonavir plus two NRTIs, including its non-inferiority design, time-to-event endpoint, risk-difference estimates, confidence intervals, and statistical interpretation.